GIC
LRCX icon

Generali Investments CEE’s Lam Research LRCX Stock Holding History

Generali Investments CEE’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Sell
3,041
-773
-20% -$235K 0.06% 253
2026
Q1 		$815K Buy
+3,814
New +$853K 0.04% 302

Other funds holding LRCX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Generali Investments CEE's LRCX Position: Q2 2026 in Review

Generali Investments CEE reduced its Lam Research (LRCX) stake by 20% in Q2 2026, selling an estimated $235K and leaving 3,041 shares worth $1.32M. The position accounts for 0.06% of the portfolio, ranked #253.

Generali Investments CEE first reported a position in LRCX in Q1 2026 and has held it in 2 quarters since. 3,123 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Generali Investments CEE held 3,041 shares of Lam Research worth $1.32M as of Q2 2026.
  • Generali Investments CEE sold 773 Lam Research shares in Q2 2026, an estimated $235K.
  • Lam Research made up 0.06% of Generali Investments CEE's portfolio in Q2 2026, its #253 holding.
  • Generali Investments CEE first reported a position in Lam Research in Q1 2026 and has held it in 2 quarters since.
  • 3,123 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.